Larkin Finbar News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Larkin Finbar. Real-time updates on events, politics, business and more.

SVB Securities Keeps Their Buy Rating on Jazz Pharmaceuticals (JAZZ)

June 7, 2023

In a report released on June 4, Marc Goodman from SVB Securities maintained a Buy rating on Jazz Pharmaceuticals (JAZZ &#8211; Research Report)....

Source: businessinsider.com

April 8, 2023

RBC Capital analyst Gregory Renza maintained a Buy rating on Jazz Pharmaceuticals (JAZZ &#8211; Research Report) on April 6 and set a price targ...

Source: businessinsider.com

March 14, 2023

Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Jazz Pharmaceuticals (JAZZ &#8211; Research Report) today and set a...

Source: businessinsider.com